Related Experiment Video
Updated: Nov 7, 2025

A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis
Published on: May 14, 2013
In-stent repeated thrombosis secondary to coronary artery aneurysms percutaneous coronary intervention in Behchet's
Minglian Gong1,2, Yi Mao3, Jinghua Liu2
1Department of Cardiology Dalian The Fifth People's Hospital Liaoning China.
Insights
Coronary artery aneurysms are a rare Behcet's disease complication. Percutaneous treatments often fail, necessitating long-term follow-up and anticoagulation to prevent thrombosis.
Area of Science:
- Cardiology
- Rheumatology
- Vascular Medicine
Background:
- Behcet's disease (BD) is a rare systemic vasculitis.
- Coronary artery aneurysm (CAA) is an uncommon but severe manifestation of BD.
- Acute coronary syndrome (ACS) in BD patients presents unique challenges.
Observation:
- Percutaneous treatment strategies for CAA in BD have shown limited success in ameliorating ACS.
- The long-term prognosis and risks associated with percutaneous intervention for coronary involvement in BD remain largely unknown.
Findings:
- Coronary artery aneurysms in Behcet's disease are associated with a poor prognosis.
- Percutaneous interventions for CAA in BD frequently fail to resolve acute coronary syndromes.
- Long-term follow-up is crucial due to unknown risks of disease progression post-intervention.
Implications:
- Long-term anticoagulant and antiplatelet therapies are recommended to prevent thrombosis and embolism in BD patients with CAA.
- Further research is needed to establish optimal management strategies for coronary involvement in Behcet's disease.
- Understanding the long-term outcomes of percutaneous interventions is vital for guiding clinical practice.
Abstract:
Coronary artery aneurysm (CAA) is a rare and poor prognostic manifestation of Behcet's disease (BD). Percutaneous treatment approaches frequently failed to ameliorate acute coronary system (ACS). Long-term follow-up is recommended as the prognosis of coronary involvement and the risk of further disease progression with percutaneous intervention in BD are unknown. long-term anticoagulant and antiaggregant therapies should be considered to prevent further thrombosis and/or embolism.
More Related Videos
Related Concept Videos
Aneurysm III: Interprofessional Care
Coronary Artery Disease V: Interprofessional Care
Peripheral Artery Disease III: Interprofessional Care
Pericarditis III: Medical Management
Atherosclerosis III: Management
Aneurysm II: Clinical Manifestations and Diagnostic Studies

